TELA Bio to Announce Fourth Quarter and Full Year 2022 Financial Results
28 févr. 2023 07h00 HE
|
TELA Bio, Inc.
MALVERN, Pa., Feb. 28, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24 févr. 2023 16h02 HE
|
TELA Bio, Inc.
MALVERN, Pa., Feb. 24, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
TELA Bio Announces U.S. Commercial Launch of Two New OviTex® LPR Device Configurations to Repair Large Abdominal Hernias Using Robotic and Laparoscopic Techniques
21 févr. 2023 07h00 HE
|
TELA Bio, Inc.
MALVERN, Pa., Feb. 21, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical...
TELA Bio Awarded Biosynthetic Mesh Products Agreement with a National Group Purchasing Organization
14 févr. 2023 07h00 HE
|
TELA Bio, Inc.
MALVERN, Pa., Feb. 14, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20 janv. 2023 16h05 HE
|
TELA Bio, Inc.
MALVERN, Pa., Jan. 20, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
TELA Bio Announces U.S. Commercial Launch of NIVIS™ Fibrillar Collagen Pack, The Natural Restoration Solution to Support Healing of Surgical Wounds
09 janv. 2023 07h00 HE
|
TELA Bio, Inc.
MALVERN, Pa., Jan. 09, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical...
TELA Bio to Participate in the 41st Annual J.P. Morgan Healthcare Conference
21 déc. 2022 07h00 HE
|
TELA Bio, Inc.
MALVERN, Pa., Dec. 21, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09 déc. 2022 16h02 HE
|
TELA Bio, Inc.
MALVERN, Pa., Dec. 09, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
TELA Bio to Participate in Piper Sandler 34th Annual Healthcare Conference
21 nov. 2022 07h00 HE
|
TELA Bio, Inc.
MALVERN, Pa., Nov. 21, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio Reports Third Quarter 2022 Financial Results
09 nov. 2022 16h01 HE
|
TELA Bio, Inc.
MALVERN, Pa., Nov. 09, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...